Fundraising FoxForge Biologics
Grove City, US · Founded 2020 · Delaware LLC · 3 known investors
Find your way into Forge Biologics
Sign up to see every warm intro you have to Forge Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Forge Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Forge Biologics is a US-based gene therapy CDMO (contract development and manufacturing organization) offering AAV manufacturing services, technologies, and infrastructure. It supports gene therapy developers across early development, clinical trials, and commercial production, and is a subsidiary of the Ajinomoto Group.
Founders & leadership
Forge Biologics was founded in 2020 by Timothy J. Miller.
Board
Investors · 3
How we know: Aisling Capital's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: Drive Capital's portfolio page · a partner's Signal profile · board seat on SEC Form D · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$250M disclosed across 3 of 4 rounds · 2020–2022
- $90MSeries CSep 2022 · 3 sourcesSource ↗
▶$120MraisedMay 2021 · 13 investors · BiotechnologyRule 506(b)
- Frederick CalloriDirector
- Timothy J. MillerExecutive Officer, Director
- Molly BonakdarpourDirector
- Matthew HammondDirector
- Chris GarabedianDirector
- Offering amount
- $120M
- Amount sold
- $120M
- Sales commissions
- $4.3M
- First sale
- Apr 2021
- Incorporated
- Limited Liability Company, Delaware, 2020
- Federal exemptions
- 06b
▶$40MraisedAug 2020 · 2 investors · BiotechnologyRule 506(b)
- Chris GarabedianDirector
- Molly McCartinDirector
- Timothy J. MillerExecutive Officer, Director
- Offering amount
- $40M
- Amount sold
- $40M
- First sale
- Jul 2020
- Incorporated
- Limited Liability Company, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Forge Biologics went on to found or lead other companies.
In the news
Frequently asked questions
- What does Forge Biologics do?
- Forge Biologics is a US-based gene therapy CDMO (contract development and manufacturing organization) offering AAV manufacturing services, technologies, and infrastructure. It supports gene therapy developers across early development, clinical trials, and commercial production, and is a subsidiary of the Ajinomoto Group.
- Who founded Forge Biologics?
- Forge Biologics was founded by Timothy J. Miller in 2020.
- Who are Forge Biologics's investors?
- Forge Biologics's investors include Aisling Capital, Drive Capital, RA Capital.
- How much funding has Forge Biologics raised?
- Forge Biologics has disclosed $250M raised across 3 of its 4 known rounds.
- Where is Forge Biologics headquartered?
- Forge Biologics is headquartered in Grove City, US.